Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Therapeutic Drug Monitoring|May 1, 1991
Particle concentration fluorescence immunoassay of gentamicinP Varma-Nelson, J E Nelson, S M Belknap
Clinical Pharmacology and Therapeutics|June 24, 2010
Quality of methods for assessing and reporting serious adverse events in clinical trials of cancer drugsS M Belknap, C H Georgopoulos, D P West, et al.
Clinical Pharmacology and Therapeutics|July 1, 1987
Effect kinetics of N-acetylprocainamide-induced QT interval prolongationA A Piergies, T I Ruo, E M Jansyn, et al.
Clinical Pharmacology and Therapeutics|July 1, 1988
Acute tolerance to cocaine in humansJ J Ambre, S M Belknap, J Nelson, et al.
The Journal of Clinical Endocrinology and Metabolism|November 4, 2000
Relation of plasma oxytocin and prolactin concentrations to milk production in mothers of preterm infants: influence of stressR T Chatterton, P D Hill, J C Aldag, et al.
Pharmacotherapy|November 18, 2000
Pharmaceutical care of postoperative nausea and vomiting: balanced scorecard for outcomesJ F Graumlich, S M Belknap, S A Bullard, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1987
Theophylline distribution kinetics analyzed by reference to simultaneously injected urea and inulinS M Belknap, J E Nelson, T I Ruo, et al.
The Journal of Infectious Diseases|November 7, 1998
A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP Study GroupS Nelson, S M Belknap, R W Carlson, et al.
Journal of Clinical Pharmacology|September 14, 2013
Reporting of serious adverse events during cancer clinical trials to the institutional review board: an evaluation by the research on adverse drug events and reports (RADAR) projectS M Belknap, C H Georgopoulos, J Lagman, et al.
Clinical Pharmacology and Therapeutics|April 5, 2008
Application of software design principles and debugging methods to an analgesia prescription reduces risk of severe injury from medical use of opioidsS M Belknap, H Moore, S A Lanzotti, et al.
Pageof 2